5Szymanski S, Lieberman dif-ference in onset of JA, Alvir JM, et al. Gender illness, treatment response, course, and biologic in -dexes in firstepisode schizophrenic patients[J].Am J Psychiatry,1995,(152):698-703.
6Grunder G, Wetzel H, Schlosser R, et al. Neuroendocrine response to antipsychotics: effects of drug typr and gender[J]. Biol P sychiatry, 1999,(45):89-97.
7Kapur S,Seeman P, Does fast dissociation from the dopamine d(2)receptor explain the action of atypical antipsychotics:a new hypothesis[J].Am J Psychiatry,2001, ( 158 ) : 360-369.
8Nordstrom AL,Farde L.Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patinents[J].J Clin Psychopharmacol, 1998, ( 18 ) : 305-310.
9Biller BM. Lueiano A,Crosignani PQ,et al.Guidelines for the diagnosis and treatment of hyperprolatinemia J Reprod Med[J].1999,44(12 Suppl):1075-1084.
10Van Putten T,Marder SR,Mintz J.Serum prolactin as a correlate of clinical response to haloperidal[J].Clin Psychopharmacol, 1911,11 (6) : 357.
